Menivim REIT: What the Shaniv Deal Really Adds to Shareholders
The main article already framed the post-balance-sheet deal wave around one question: what actually reaches shareholders. Shaniv adds a relatively stable NOI layer, but most of the eye-catching numbers are still disclosed on a 100%-basis asset view, while the larger upside still needs capital, closing and execution.
What This Deal Really Tests
The main article already made the broader point: Menivim's core portfolio looks stable, but the 2026 test sits in whether the post-balance-sheet deal wave turns into value that actually reaches shareholders. Shaniv is the cleanest case for that test because almost every attractive headline is already there in the disclosure: about NIS 201 million of asset value, about NIS 11 million of current annual NOI, about NIS 13 million of annual NOI at full occupancy of the built assets, long NNN leases, and a future development plan.
That is also exactly where the read can go wrong. Menivim is not buying 100% of the assets themselves. It is buying 51% of Shaniv Nadlan. The company also says Shaniv's financial statements will be consolidated into Menivim's own. So the raw reported numbers can look large in the consolidated statements while the economics that truly belong to Menivim shareholders are narrower.
The right framing starts with one simple bridge. Out of roughly NIS 11 million of current annual NOI at Shaniv, Menivim's economic share is about NIS 5.6 million. Out of roughly NIS 13 million of annual NOI at full occupancy of the built assets, Menivim's share is about NIS 6.6 million. Against Menivim's own 2025 NOI of about NIS 237.3 million, that is only about 2.4% to 2.8%. It is additive. It is not a standalone change in Menivim's economics.
| Layer | Disclosed figure | What it means for Menivim shareholders |
|---|---|---|
| Shaniv asset value | About NIS 201 million | This is the asset pool on a 100% basis |
| Menivim's share of asset value | About NIS 103 million | This is gross economic exposure at the asset layer, not the purchase price |
| Purchase consideration | About NIS 56.4 million | This is the check for 51% of the shares, not for 100% of the real estate |
| Deal expenses | About NIS 8.2 million | Extra entry cost on top of the headline price |
| Current annual NOI | About NIS 11 million | A 100%-basis Shaniv metric |
| Menivim's share of current NOI | About NIS 5.6 million | Menivim's economic share before financing, tax and corporate overhead |
| Annual NOI at full occupancy of the built assets | About NIS 13 million | This still excludes the future development upside |
| Menivim's share at that level | About NIS 6.6 million | The nearer-term upside, still before further layers |
Where the Big Numbers Can Mislead
The number that grabs attention first is the gap between about NIS 201 million of asset value and a purchase price of about NIS 56.4 million. That is not free value. The disclosure says the consideration was calculated mainly on the basis of Shaniv Nadlan's equity plus deferred taxes. In other words, anyone reading the transaction as if Menivim were buying NIS 201 million of assets for NIS 56.4 million is skipping the critical layer: the company is buying equity in a real-estate vehicle, not buying the real estate itself on a clean, asset-only basis.
The same discipline applies to NOI. The NIS 11 million and NIS 13 million figures sit at Shaniv's level. Menivim will gain control and will consolidate the vehicle, but 49% of the economics still remain with the partner. So the correct read is not "Menivim adds NIS 11 million to NIS 13 million of NOI." The correct read is "Menivim adds roughly NIS 5.6 million to NIS 6.6 million of economic NOI before further layers."
If one looks only at gross asset-layer economics, the deal does look decent. Menivim's current share of NOI, about NIS 5.6 million, implies roughly 9.9% on the headline purchase consideration, or about 8.7% if the disclosed deal expenses are included. On the NIS 6.6 million full-occupancy share of the built assets, that rises to roughly 11.8% on the consideration or about 10.3% on the total disclosed entry cost. But that is still an asset-layer yield, not a common-shareholder yield. To become full value for Menivim shareholders, it still has to travel through minorities, financing, tax and time.
What Menivim Is Really Buying on Day One
At the immediate economic level, this deal looks more like a package of long leases tied to one anchor tenant than like a broad new diversification engine. Out of about NIS 11 million of current annual NOI, around NIS 10 million comes from assets leased to Shaniv Industries itself, while only about NIS 1 million comes from third parties. In plain terms, almost all of the current NOI depends on the same tenant that is selling Menivim the controlling stake in the real-estate company.
That is not automatically a negative. In fact, it gives the deal a fairly visible base case. The leases with Shaniv Industries run for 13 to 20 years and are structured as NNN leases. That creates a clear rent stream, and precisely because such a large part of the income is tied to one tenant, the reader can see more clearly what Menivim is buying. But it should be called by its real name: this is first a concentrated NOI package around one anchor tenant, and only after that a diversification story.
The filing adds one more important detail. The shareholder agreement says Menivim will handle Shaniv Nadlan's day-to-day management. That matters because Menivim is not entering as a passive financial investor. It is buying operational control, accounting control and the ability to lead the next improvement phase. That helps explain why the company is willing to look beyond the rent stream that already exists.
Where the Real Upside Sits
If one stops at the NIS 13 million of annual NOI, the strategic reason for the deal is only half visible. The NIS 13 million relates to full occupancy of the built structures on the acquired properties. The larger upside sits elsewhere: vacant land of about 20 dunams, additional rights of about 20,000 square meters in the Ofakim industrial area, and the parties' stated intention to invest about NIS 100 million in Shaniv Nadlan's development over the coming years.
That is where the deal becomes much more interesting, but also much less immediate. The future value does not come from a sharp jump in today's NOI. It comes from whether Menivim can turn control over an industrial real-estate platform in Ofakim into development that earns an attractive return. That is no longer a pure existing-rent story. It is a development and execution story. Anyone who already gives the deal all of that upside today is getting ahead of the evidence. Anyone who ignores it entirely is missing why Menivim bought control rather than just another single asset.
This is why the deal should be read through two very different engines. The first is long-duration rent on built assets, producing a relatively modest but visible NOI addition. The second is a development option that could become more valuable, but still needs capital, timing, leasing and execution. Both engines are present in the same transaction, and only one of them belongs to shareholders in cash terms on day one.
Where the Friction Still Sits
This transaction has not yet reached the stage where it should be treated as closed NOI. Completion is still subject to approvals from the Competition Authority and financing institutions, as well as to a first-ranking charge and a mortgage-registration undertaking at the Israel Land Authority. Beyond that, if rights in the relevant asset are not transferred by the agreed deadlines, Menivim may cancel the deal as to that asset against a proportional refund, and for Plot 203 in Ofakim there is also a right to cancel the entire share-purchase agreement if the transfer of rights is not completed on time.
That is exactly where "good assets" still do not automatically equal "shareholder value." Until the deal closes, until the registrations are completed, and until the development plans acquire a financing and execution shape, Menivim shareholders mainly have a promising option rather than locked-in value.
There is also a real cost layer. The company says the purchase price will be paid from its cash balances. Against cash of about NIS 195 million at year-end 2025, the consideration alone equals roughly 29% of the cash box, and the ratio rises to about 33% if the disclosed deal expenses are also included. This is not a full funding analysis, and it does not mean that the actual cash balance at closing will look exactly like that after everything that happened later. But as a shareholder reference point, it matters. Menivim is buying a fairly moderate day-one cash-flow addition together with a more ambitious development option for the period after that.
Conclusion
Bottom line: the Shaniv deal looks better when it is broken into two floors. The first floor is a control acquisition in an industrial and logistics real-estate vehicle that adds roughly NIS 5.6 million to NIS 6.6 million of annual NOI to Menivim's economic share before financing, supported by long NNN leases and fairly good visibility. The second floor is an Ofakim development option that could become more important than the existing rent stream, but does not yet belong to shareholders as cash flow, certainly not as clean cash flow.
That is why the right reading sits in the middle. Anyone who already credits Menivim with the full NIS 201 million of asset value and the full NIS 11 million to NIS 13 million of NOI is overstating what reaches shareholders. Anyone who sees only a small extra NOI layer is missing that Menivim is also buying control and a future development pipe.
What enters the shareholder pocket today is an additive move, not a game changer. What could make the transaction genuinely large will depend on whether the closing is completed, whether Ofakim development takes shape, and whether Menivim can turn asset-level control into value that really reaches the listed-shareholder layer.
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.